| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0047 | 0.9 |